Brief: Biosynex Announces Acquisition Of A 75% Stake In BHR Pharmaceuticals
May 19 (Reuters) - Biosynex SA ALBIO.PA :
* BIOSYNEX ANNOUNCES IT HAS ACQUIRED A 75% STAKE IN BHR
PHARMACEUTICALS LTD
* THE SYNERGIES EXPECTED FROM THIS APPROACH SHOULD ALLOW
BIOSYNEX
AND BHR TO REACH A COMBINED TURNOVER OF NEARLY £10 MILLION IN 4
YEARS
Source text for Eikon: ID:nEQhYBDxa
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals